Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Fate Therapeutics is seeking an Executive Director, Clinical Operations to contribute to the strategy and lead execution of our global clinical operations across multiple cell therapy franchises. In this senior leadership role, you will drive the planning and delivery of studies built on a differentiated, off-the-shelf platform designed for broad patient access.
Partnering closely with the executive team, clinical leadership, and cross-functional colleagues, you will shape portfolio priorities,
Fate Therapeutics is seeking an Executive Director, Clinical Operations to contribute to the strategy and lead execution of our global clinical operations across multiple cell therapy franchises. In this senior leadership role, you will drive the planning and delivery of studies built on a differentiated, off-the-shelf platform designed for broad patient access. Partnering closely with the executive team, clinical leadership, and cross-functional colleagues, you will shape portfolio priorities, ensure operational excellence in site start-up, enrollment, and data quality, and own the timelines and budgets that bring our pipeline to patients. If you are a strategic, hands-on leader who thrives on building high-performing teams and scalable processes, this is an opportunity to make a meaningful impact on the future of cell therapy in autoimmune disease.
The preceding job description indicates the general nature and level of work performed by employees within this classification. Additional and incidental duties related to the primary duties may be required from time to time.
Fate Therapeutics, Inc. is an equal opportunity employer. We value diversity and are committed to creating an inclusive environment for all employees.
To learn about how Fate collects and uses job application information, please visit Fate's online Privacy Notice.
Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients. Using its proprietary iPSC product platform, the Company has established a leadership position in creating multiplexed-engineered master iPSC lines and in the manufacture and clinical development of off-the-shelf, iPSC-derived cell products. The Company's pipeline includes iPSC-derived T-cell and natural killer (NK) cell product candidates, which are selectively designed, incorporate novel synthetic controls of cell function, and are intended to deliver multiple therapeutic mechanisms to patients. Fate Therapeutics is headquartered in San Diego, CA. For more information, please visit www.fatetherapeutics.com.